Literature DB >> 28119317

Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin.

Antonio Sorlózano-Puerto1, José María Navarro-Marí2, José Gutiérrez-Fernández3,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28119317      PMCID： PMC5278721          DOI： 10.1128/AAC.02317-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis.

Authors:  Juan Aguilar-Company; Ibai Los-Arcos; Carles Pigrau; Dolors Rodríguez-Pardo; María Nieves Larrosa; Virginia Rodríguez-Garrido; Denisse Sihuay-Diburga; Benito Almirante
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

2.  Fatal Campylobacter jejuni ileocolitis.

Authors:  Marta Magaz Martínez; Aurelio Garrido Botella; Fernando Pons Renedo; Borja Oliva Del Río; Bélen Agudo Castillo; Pilar Ibarrola Arévalo; Luis Esteban Abreu García
Journal:  Rev Esp Enferm Dig       Date:  2016-10       Impact factor: 2.086

Review 3.  Antimicrobial resistance in campylobacter: susceptibility testing methods and resistance trends.

Authors:  Beilei Ge; Fei Wang; Maria Sjölund-Karlsson; Patrick F McDermott
Journal:  J Microbiol Methods       Date:  2013-07-01       Impact factor: 2.363

4.  Infectious etiology of diarrheas studied in a third-level hospital during a five-year period.

Authors:  Antonio Damián Sánchez-Capilla; Antonio Sorlózano-Puerto; Javier Rodríguez-Granger; Antonio Martínez-Brocal; José María Navarro-Marí; José Gutiérrez-Fernández
Journal:  Rev Esp Enferm Dig       Date:  2015-02       Impact factor: 2.086
  4 in total
  2 in total

1.  Reply to "Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin".

Authors:  Juan Aguilar-Company; Ibai Los-Arcos; Carlos Pigrau; Benito Almirante
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

2.  In vitro activity of fosfomycin against Campylobacter isolates from poultry and wild birds.

Authors:  Bai Wei; Min Kang
Journal:  PLoS One       Date:  2018-07-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.